Synthes buys Anspach to create $200m power tools division
This article was originally published in Clinica
Executive Summary
Synthes has secured its first acquisition for over two years by snapping up The Anspach Effort, a high-speed surgical tools manufacturer. The deal, of which financial terms were undisclosed, sees Synthes add a portfolio of tools used in neurosurgery, spinal and ear, nose and throat procedures.